Jpmorgan Chase & CO Nuvasive Inc Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.71 - $44.15 $3.14 Million - $3.77 Million	-85,412 Reduced 33.86%	166,808 $6.94 Million
Q1 2023 May 18, 2023	BUY	$36.81 - $48.12 $2.55 Million - $3.33 Million	69,252 Added 37.85%	252,220 $10.4 Million
Q1 2023 May 11, 2023	SELL	$36.81 - $48.12 $69.6 Million - $91 Million	-1,890,469 Reduced 91.18%	182,968 $7.56 Million
Q4 2022 Feb 13, 2023	SELL	$35.68 - $44.71 $10.9 Million - $13.7 Million	-306,859 Reduced 12.89%	2,073,437 $85.5 Million
Q3 2022 Nov 14, 2022	SELL	$42.51 - $54.02 $23.7 Million - $30.1 Million	-557,999 Reduced 18.99%	2,380,296 $104 Million
Q2 2022 Aug 11, 2022	SELL	$46.84 - $59.75 $6.45 Million - $8.23 Million	-137,709 Reduced 4.48%	2,938,295 $144 Million
Q1 2022 May 11, 2022	BUY	$48.09 - $57.79 $2.39 Million - $2.87 Million	49,684 Added 1.64%	3,076,004 $174 Million
Q4 2021 Feb 10, 2022	BUY	$47.19 - $62.68 $5.12 Million - $6.8 Million	108,526 Added 3.72%	3,026,320 $159 Million
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $166 Million - $198 Million	2,917,794 New	2,917,794 $175 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.